Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Aug;73(2):214-8.

Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies

Affiliations

Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies

M Massaia et al. Clin Exp Immunol. 1988 Aug.

Abstract

The generation of cytotoxic T lymphocytes (CTL) towards allogeneic cells was investigated in 19 patients with monoclonal gammopathy of undetermined significance (MGUS) and 31 patients with multiple myeloma (MM). This function was significantly decreased in all patients. The cytotoxic deficiency was more pronounced in MM with poor prognosis than MM with good prognosis and MGUS patients. A phenotypic analysis of PBT lymphocytes showed that poor prognosis MM also had the highest proportions of activated cells (HLA-DR+) in CD8+ subpopulations. CTL were generated after depletion of CD11+ lymphocytes (including suppressor cells) or after inhibition of suppressor function with deoxyguanosine. No increase of cytotoxicity was detected under these conditions. Exogenous supplementation of recombinant interleukin 2 (rIL-2) was also ineffective. These data indicate that MG PBT lymphocytes are unable to fully differentiate into CTL following allogeneic stimulation. This deficiency is most evident in MM patients already showing the poorest prognosis and the most altered T cell phenotype.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1970 Apr;49(4):673-80 - PubMed
    1. Clin Exp Immunol. 1987 Aug;69(2):426-32 - PubMed
    1. J Immunol. 1980 Jun;124(6):2563-70 - PubMed
    1. Nature. 1980 Jun 12;285(5765):494-6 - PubMed
    1. J Immunol. 1980 Sep;125(3):1269-74 - PubMed

Publication types

LinkOut - more resources